In Q4 FY25, Pfizer's profit came at Rs 330.94 crore as against Rs 178.86 crore during the previous quarter ended March 2024. The company's sales climbed 8 per cent to Rs 591.91 crore in the quarter ended March 2025 compared to Rs 546.63 crore in the year-ago period.
RBI G-Sec auction, ONGC, HAL, Apollo Hospitals, Nykaa Q1 Results in Top News on Aug 11: Airtel, BHEL ex dividend stocks, Nifty outlook, Ather 450S e-scooter and TVS Raider Marvel Edition launch also in focus in top stories today.
Hot stocks in focus: Benchmark indices ended higher on Friday amid mixed trend in the global markets. Vedanta, ITC, Tata Motors, Jindal Steel, Bharti Airtel among hot stocks to watch out for in the week of May 15.
Microsoft Corp rose 2.89% following the tech giant's deal to buy a 4% stake in the London Stock Exchange Group, helping to boost each of the three major indexes.
Pfizer stock fell 5.53% intra day to Rs 5,177.5 on BSE. It closed 4.77% lower at Rs 5,219 on BSE.
Pfizer is one of many companies racing to bring COVID-19 vaccines to market, seen as essential to ending a pandemic that has claimed more than 655,000 lives globally
The COVID-19 vaccine developed by German biotech firm BioNTech and the US pharmaceutical giant has shown potential and was found to be well tolerated in early-stage human trials testing of 45 people
In Q4 FY20, Pfizer posted 5.9 per cent decline in net profit at Rs 103 crore compared to Rs 109.5 crore in the corresponding period last year
During the January-March quarter, Pfizer's net profit grew by 4.74 per cent to Rs 109.47 crore from Rs 104.5 1 crore in the same period last year





